These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7717711)

  • 1. [Phase II study].
    Niitani H
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):607-10. PubMed ID: 7717711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
    Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
    Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Second-line and beyond: Docetaxel in the treatment of non-small-cell lung cancer].
    Rinaldi M
    Tumori; 2001; 87(6):A6-9. PubMed ID: 11995708
    [No Abstract]   [Full Text] [Related]  

  • 4. New chemotherapeutic agents in the treatment of non-small cell lung cancer: the Australian experience.
    Boyer MJ
    Chest; 1998 Jan; 113(1 Suppl):24S-27S. PubMed ID: 9438686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Docetaxel].
    Takigawa N
    Nihon Rinsho; 2002 May; 60 Suppl 5():349-52. PubMed ID: 12101686
    [No Abstract]   [Full Text] [Related]  

  • 6. [New wave of chemotherapeutic agents: update in pulmonary oncology].
    Sculier JP
    Rev Mal Respir; 1997 Apr; 14(2):154-6. PubMed ID: 9198842
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent advances in managing non-small-cell lung cancer: 4. Chemotherapy of metastatic cancer.
    Clarke SJ; Boyer MJ
    Med J Aust; 1997 Jun; 166(S1):S14-6. PubMed ID: 9201199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
    Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for non-platinum chemotherapy in advanced NSCLC.
    Murren JR
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New cytostatics in the therapy of non-small cell bronchial carcinoma].
    Serke M; Schönfeld N; Loddenkemper R
    Pneumologie; 1998 Jun; 52(6):333-7. PubMed ID: 9715648
    [No Abstract]   [Full Text] [Related]  

  • 11. Docetaxel and gemcitabine released for cancer chemotherapy.
    Am J Health Syst Pharm; 1996 Jul; 53(14):1643, 1649. PubMed ID: 8827226
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy with docetaxel in non--small cell lung cancer.
    Mattson K
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):33-6. PubMed ID: 11441413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising new agents in the treatment of non-small cell lung cancer.
    Edelman MJ; Gandara DR
    Cancer Chemother Pharmacol; 1996; 37(5):385-93. PubMed ID: 8599859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.
    Hainsworth JD; Burris HA; Greco FA
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):21-5. PubMed ID: 11441411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New chemotherapeutic agents for non-small cell lung cancer.
    Miller VA; Rigas JR; Grant SC; Pisters KM; Kris MG
    Chest; 1995 Jun; 107(6 Suppl):306S-311S. PubMed ID: 7781411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of granulocyte growth factors in the treatment of non small cell lung cancer.
    Gridelli C; Barzelloni ML; Barletta E; Guida C; Gatani T; Fiore F; Scognamiglio F
    Clin Ter; 1999; 150(3):231-4. PubMed ID: 10528437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?
    Ferrigno D; Buccheri G
    Lung Cancer; 2000 Aug; 29(2):91-104. PubMed ID: 10963840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung cancer].
    Furuse K
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1917-24. PubMed ID: 9350236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of taxanes in lung-cancer chemotherapy.
    Schiller JH
    Cancer Invest; 1998; 16(7):471-7. PubMed ID: 9774954
    [No Abstract]   [Full Text] [Related]  

  • 20. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.